Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Assay for Inhibition of Compounds Provided in the Present Application on CYP Enzymes from US Patent US20240226107: "UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR"
Assay data:1 Active, 2 Tested
SummaryRelated BioAssays by Target
The Inhibitory Effect of the Compound on the Activity of Human Liver Microsomal Cytochrome P450 Isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) from US Patent US12030897: "Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof"
Assay data:1 Tested
CYP450 Enzyme Inhibition Assay from US Patent US20240216357: "POLYCYCLIC COMPOUND AND APPLICATION THEREOF"
Assay data:10 Active, 23 Tested
CYP450 Enzyme Inhibition Assay from US Patent US20240208932: "ARYLAMINO DERIVATIVE ESTROGEN RECEPTOR MODULATOR AND USE THEREOF"
Assay data:4 Tested
Inhibition of Cytochrome P450 Oxidase from US Patent US20240158438: "POLYPEPTIDE COMPOUND AND APPLICATION THEREOF"
Assay data:2 Active, 31 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
CYP Enzyme Inhibition Assay from US Patent US11981669: "1,7-naphthyridine derivative and preparation method and use therefor"
Assay data:8 Tested
SummaryRelated BioAssays by DepositorRelated BioAssays by Target
CYP Enzyme Inhibitory Activity IC50 Assay from US Patent US20240124479: "PYRIMIDINE CARBOXAMIDE COMPOUND AND USE THEREOF"
Enzymatic Activity of CYP2C9, CYP2D6, and CYP3A4 from US Patent US20240124454: "TRICYCLIC COMPOUND AND USE THEREOF"
Assay data:10 Tested
CYP inhibitio from US Patent US20240124434: "ATF6 INHIBITORS AND USES THEREOF"
Assay data:10 Active, 3 Activity ≤ 1 µM, 17 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibitory Activity Assay from US Patent US11952364: "TRK inhibitors useful as anticancer drugs"
Assay data:3 Active, 1 Activity ≤ 1 µM, 3 Tested
Cross screening panel
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate at 10 uM preincubated for 10 mins followed by NADPH addition and measured after 15 mins by LC-MS/MS analysis
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of CYP3A4 (unknown origin)
Assay data:3 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of CYP3A4 in human liver microsomes incubated for 10 mins in presence of NADPH by LC/MS/MS analysis
Assay data:2 Tested
Time dependent inhibition of CYP3A4 in human liver microsomes assessed as residual activity at 5 uM using midazolam as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by LC-MS/MS analysis relative to control
Reversible inhibition of CYP3A4 in human liver microsomes assessed as residual activity at 5 uM using midazolam as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by LC-MS/MS analysis relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on